Casdin Capital, LLC Biolife Solutions Inc Transaction History
Casdin Capital, LLC
- $855 Million
- Q1 2025
A detailed history of Casdin Capital, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Casdin Capital, LLC holds 8,707,165 shares of BLFS stock, worth $197 Million. This represents 23.27% of its overall portfolio holdings.
Number of Shares
8,707,165
Previous 8,707,165
-0.0%
Holding current value
$197 Million
Previous $226 Million
12.02%
% of portfolio
23.27%
Previous 19.45%
Shares
13 transactions
Others Institutions Holding BLFS
# of Institutions
200Shares Held
47.1MCall Options Held
2.5KPut Options Held
172K-
Black Rock Inc. New York, NY5.49MShares$124 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.55MShares$80.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$65.7 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.53MShares$34.8 Million0.21% of portfolio
-
State Street Corp Boston, MA1.43MShares$32.5 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $968M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...